Furthermore, this study did not identify any correlation between Gli1 or Ptch1 expression and poor clinical outcomes in ERMS and gene-fusion-negative ARMS patients (Pressey et al. 2011). This evidence concerns the gene GLI1 and alveolar rhabdomyosarcoma.